UNSPSC 51131660: Danaparoid

This classification denotes a low molecular weight heparin with the molecular formula C14H18NO17S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BI6GY4U9CW, more generally known as danaparoid. European Medicines Agency schedules Danaparoid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13531MIG. As of Q4 2014, DANAPAROID remains the US FDA Preferred Term for this commodity. SMILES: NONE.

UNSPSC 51131660 Danaparoid is a Commodity code that nominally designates anticoagulant pharmaceuticals, but the recent state and local solicitation activity under this code does not reflect pharmaceutical procurement. Sourcewell, a Minnesota cooperative purchasing entity, issued RFP #061626 in May 2026 seeking law enforcement equipment on behalf of participating counties and public entities across multiple states — a scope unrelated to the pharmaceutical code's stated purpose. The mismatch between the code's nominal classification and the actual work being solicited suggests either a data classification error in the opportunity record or non-standard tagging by the issuing body. No additional recent opportunities under this code are present in the source material.

The single documented opportunity targets a multi-state cooperative purchasing vehicle administered through Sourcewell, with participating jurisdictions including Washington counties (Franklin, Grant, Grays Harbor, Chelan, and Yakima) and numerous other public entities across the United States and Canada. Sourcewell accepted proposals through its portal until June 16, 2026, 3:30 p.m. Central Time. Given the absence of additional recent opportunities and the fundamental mismatch between the code's pharmaceutical designation and the law enforcement equipment scope actually being procured, this code shows little relevant activity for pharmaceutical-focused business development at this time.